Ulf Seifart

1.2k total citations
46 papers, 820 citations indexed

About

Ulf Seifart is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Ulf Seifart has authored 46 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Epidemiology. Recurrent topics in Ulf Seifart's work include Cancer survivorship and care (10 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Medical Practices and Rehabilitation (5 papers). Ulf Seifart is often cited by papers focused on Cancer survivorship and care (10 papers), Childhood Cancer Survivors' Quality of Life (8 papers) and Medical Practices and Rehabilitation (5 papers). Ulf Seifart collaborates with scholars based in Germany, Switzerland and United States. Ulf Seifart's co-authors include Carola Seifart, Winfried Rief, P. von Wichert, Mareike Hofmann, Alexandra Plagens, Claus Vogelmeier, Christian Görg, Astrid Dempfle, Jorge Riera Knorrenschild and Jan Schmielau and has published in prestigious journals such as Scientific Reports, Pain and British Journal of Cancer.

In The Last Decade

Ulf Seifart

41 papers receiving 784 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulf Seifart Germany 17 218 207 198 149 86 46 820
Helena Carreira United Kingdom 18 143 0.7× 601 2.9× 274 1.4× 111 0.7× 126 1.5× 42 1.2k
Mia Bergenmar Sweden 21 290 1.3× 584 2.8× 122 0.6× 438 2.9× 137 1.6× 47 1.3k
Angela Hardi United States 18 163 0.7× 65 0.3× 130 0.7× 69 0.5× 68 0.8× 55 923
J L Donovan United Kingdom 16 250 1.1× 161 0.8× 279 1.4× 217 1.5× 72 0.8× 27 1.2k
Bader Shirah Saudi Arabia 16 110 0.5× 61 0.3× 109 0.6× 43 0.3× 52 0.6× 147 1.1k
Jacqueline M. Stouthard Netherlands 17 156 0.7× 331 1.6× 138 0.7× 182 1.2× 47 0.5× 33 1.1k
Ahmed T. Ahmed United States 17 162 0.7× 117 0.6× 62 0.3× 90 0.6× 52 0.6× 34 1.4k
Katharine S. Gries United States 11 77 0.4× 98 0.5× 51 0.3× 41 0.3× 57 0.7× 41 618
Yunji Hwang South Korea 17 91 0.4× 173 0.8× 97 0.5× 41 0.3× 32 0.4× 30 825
Log Young Kim South Korea 12 136 0.6× 68 0.3× 107 0.5× 30 0.2× 127 1.5× 19 794

Countries citing papers authored by Ulf Seifart

Since Specialization
Citations

This map shows the geographic impact of Ulf Seifart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Seifart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Seifart more than expected).

Fields of papers citing papers by Ulf Seifart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Seifart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Seifart. The network helps show where Ulf Seifart may publish in the future.

Co-authorship network of co-authors of Ulf Seifart

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Seifart. A scholar is included among the top collaborators of Ulf Seifart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Seifart. Ulf Seifart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Seifart, Carola, Martin C. Koch, Jorge Riera Knorrenschild, et al.. (2024). Collaborative advance care planning in palliative care: a randomised controlled trial. BMJ Supportive & Palliative Care. 16(2). 448–456.
3.
Seifart, Ulf. (2023). Post-COVID—More than chronic fatigue?. Herz. 48(3). 229–233.
4.
Blanckenburg, Pia von, Jorge Riera Knorrenschild, Mareike Hofmann, et al.. (2022). Expectations, end-of-life fears and end-of-life communication among palliative patients with cancer and caregivers: a cross-sectional study. BMJ Open. 12(5). e058531–e058531. 10 indexed citations
5.
George, Carolin Elizabeth, G. Scheuch, Ulf Seifart, et al.. (2022). COVID-19 symptoms are reduced by targeted hydration of the nose, larynx and trachea. Scientific Reports. 12(1). 4599–4599. 14 indexed citations
6.
Seifart, Ulf. (2022). Sozioökonomische Risiken für Krebserkrankte – mögliche Folgen und Hilfestellungen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 65(4). 439–445. 4 indexed citations
7.
Strik, Herwig, Werner Cassel, Michael Teepker, et al.. (2021). Why Do Our Cancer Patients Sleep So Badly? Sleep Disorders in Cancer Patients: A Frequent Symptom with Multiple Causes. Oncology Research and Treatment. 44(9). 469–475. 16 indexed citations
8.
Hilgendorf, Inken, Corinna Bergelt, Carsten Bokemeyer, et al.. (2021). Long-Term Follow-Up of Children, Adolescents, and Young Adult Cancer Survivors. Oncology Research and Treatment. 44(4). 184–189. 17 indexed citations
9.
Seifart, Ulf & Jan Schmielau. (2017). Return to Work of Cancer Survivors. Oncology Research and Treatment. 40(12). 760–763. 37 indexed citations
10.
Reuß‐Borst, Monika, Pia Heußner, Ulf Seifart, et al.. (2015). Survivorship - lebenslange Begleitung von Krebspatienten. Oncology Research and Treatment. 38(Suppl. 4). 2–23. 3 indexed citations
11.
Rick, Oliver, et al.. (2012). Reintegrating Cancer Patients Into the Workplace. Deutsches Ärzteblatt international. 109(42). 702–8. 29 indexed citations
12.
Gröschel, A, Christoph Pöttgen, Martin Reck, et al.. (2011). Nachsorge, Komplikationen und deren Therapie bei der operativen, strahlentherapeutischen und medikamentösen Therapie des Lungenkarzinoms. Onkologie. 34(s4). 11–16. 1 indexed citations
13.
Seifart, Ulf, Thomas Fink, Carmen Schade‐Brittinger, et al.. (2006). Randomised phase II study comparing topotecan/carboplatin administration for 5 versus 3 days in the treatment of extensive-stage small-cell lung cancer. Annals of Oncology. 18(1). 104–109. 2 indexed citations
14.
Seifart, Carola, Astrid Dempfle, Alexandra Plagens, et al.. (2005). TNF‐α‐, TNF‐β‐, IL‐6‐, and IL‐10‐promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens. 65(1). 93–100. 76 indexed citations
15.
Seifart, Carola, Alexandra Plagens, Astrid Dempfle, et al.. (2005). TNF‐α, TNF‐β, IL‐6, and IL‐10 Polymorphisms in Patients with Lung Cancer. Disease Markers. 21(3). 157–165. 83 indexed citations
16.
Seifart, Ulf, Katrin Jensen, M. Schröder, et al.. (2005). Randomized phase II study comparing topotecan/cisplatin administration for 5 days versus 3 days in the treatment of extensive stage small cell lung cancer (SCLC). Lung Cancer. 48(3). 415–422. 15 indexed citations
17.
Seifart, Carola, Ulf Seifart, Alexandra Plagens, et al.. (2005). Rare SP‐A alleles and the SP‐A1‐6A4 allele associate with risk for lung carcinoma. Clinical Genetics. 68(2). 128–136. 19 indexed citations
18.
Seifart, Carola, et al.. (2002). Surfactant protein B gene variations enhance susceptibility to squamous cell carcinoma of the lung in German patients. British Journal of Cancer. 87(2). 212–217. 19 indexed citations
19.
Görg, Christian, et al.. (2002). Bronchioloalveolar carcinoma: sonographic pattern of ‘pneumonia’. European Journal of Ultrasound. 15(3). 109–117. 7 indexed citations
20.
Weide, Rudolf, M. Wolf, Ulrich Kaiser, et al.. (1997). Chronic eosinophilic leukaemia (CEL): a distinct myeloproliferative disease. British Journal of Haematology. 96(1). 117–123. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helena Carreira Breakdown of academic impact, for papers by Mia Bergenmar Breakdown of academic impact, for papers by Angela Hardi Breakdown of academic impact, for papers by J L Donovan Breakdown of academic impact, for papers by Bader Shirah Breakdown of academic impact, for papers by Jacqueline M. Stouthard Breakdown of academic impact, for papers by Ahmed T. Ahmed Breakdown of academic impact, for papers by Katharine S. Gries Breakdown of academic impact, for papers by Yunji Hwang Breakdown of academic impact, for papers by Log Young Kim
Rankless by CCL
2026